Qureight Ltd.. (2/5/25). "Press Release: Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis". |
2025-02-05 |
TME Pharma N.V.. (1/29/25). "Press Release: TME Pharma Announces Collaboration with Aimed Analytics for AI-Driven Drug Discovery and Optimization". Berlin. |
2025-01-29 |
OSE Immunotherapeutics S.A.. (1/29/25). "Press Release: OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy". Nantes & Paris. |
2025-01-29 |
Circio Holding ASA. (1/21/25). "Press Release: 4basebio Partners with Circio to Build and Test circVec Synthetic DNA Vectors for Genetic Medicine and Vaccines". Oslo. |
2025-01-21 |
Biosaxony e. V.. (1/16/25). "Press Release: Radiation Made in Saxony – Saxon Radiopharmacy Network nukliD Strengthens International Visibility". |
2025-01-16 |
BioMed X GmbH. (1/14/25). "Press Release: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy". Heidelberg. |
2025-01-14 |
Eckert & Ziegler SE. (1/14/25). "Press Release: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture". Berlin. |
2025-01-14 |
Daiichi Sankyo Co., Ltd.. (1/13/25). "Press Release: Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH". Tokyo & Basking Ridge, NJ. |
2025-01-13 |
ITM Isotope Technologies Munich SE. (1/13/25). "Press Release: ITM and Ariceum Therapeutics Enter into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225". Garching, Munich & Berlin. |
2025-01-13 |
GSK plc. (1/13/25). "Press Release: GSK Enters Agreement to Acquire IDRx, Inc.". London. |
2025-01-13 |
CoreMedic GmbH. (1/10/25). "Press Release: CoreMedic Announces Partnership with InnoRa for Clinical Development of Transcatheter Mitral Valve Repair Device ChordArt". Basel & Philadelphia, PA. |
2025-01-10 |
Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. |
2025-01-10 |
Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2025-01-07 |
Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2025-01-07 |
Innovent Biologics, Inc.. (1/2/25). "Press Release: Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate". San Francisco, CA & Suzhou. |
2025-01-02 |
Y-mAbs Therapeutics, Inc.. (12/23/24). "Press Release: Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare Conference". New York, NY. |
2024-12-23 |
Bruker Corporation. (12/20/24). "Press Release: Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility". Zürich. |
2024-12-20 |
Ottimo Pharma Ltd.. (12/19/24). "Press Release: Ottimo Pharma Raises over $140 Million in Series A Financing". London & Boston, MA. |
2024-12-19 |
BioAge Labs, Inc.. (12/18/24). "Press Release: BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions". Richmond, CA. |
2024-12-18 |
Mainz Biomed N.V.. (12/16/24). "Press Release: Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering". Berkeley, CA & Mainz. |
2024-12-16 |
ITM Isotope Technologies Munich SE. (12/13/24). "Press Release: ITM to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Garching / Munich. |
2024-12-13 |
Oribiotech Ltd.. (12/10/24). "Press Release: Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies". London & Bad Homburg. |
2024-12-10 |
Relation Therapeutics Ltd.. (12/10/24). "Press Release: Relation Announces Two Strategic Collaborations with GSK to Advance Therapeutics for Fibrotic Diseases and Osteoarthritis". London. |
2024-12-10 |
Formycon AG. (12/9/24). "Press Release: MS Pharma Becomes Partner for the Commercialization of FYB202 / Ustekinumab in the MENA Region". Planegg-Martinsried. |
2024-12-09 |
Muna Therapeutics ApS. (12/5/24). "Press Release: Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease". Copenhagen. |
2024-12-05 |
Eckert & Ziegler SE. (12/5/24). "Press Release: Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments". Berlin. |
2024-12-05 |
Leon-Nanodrugs GmbH. (12/5/24). "Press Release: Feasibility Study with Evonik Confirms Leon’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery". Munich, Planegg. |
2024-12-05 |
Ipsen S.A.. (12/3/24). "Press Release: Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-Class MAIT Cell Engager in Immuno-oncology". Paris. |
2024-12-03 |
Tubulis GmbH. (12/3/24). "Press Release: Gilead and Tubulis Enter into Exclusive Option and Licence Agreement to Develop ADC Candidate for Select Solid Tumor Target". Foster City, CA & Munich. |
2024-12-03 |
Orbit Discovery Ltd.. (12/3/24). "Press Release: Orbit Discovery and Evergreen Theragnostics Expand Research Collaboration to Advance Targeted Therapeutics Development". Oxford & Springfield, NJ. |
2024-12-03 |
PTC Therapeutics, Inc.. (12/2/24). "Press Release: PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program". Warren, NJ. |
2024-12-02 |
Eppendorf SE. (12/2/24). "Press Release: Eppendorf SE and DataHow AG Announce Strategic Collaboration to Advance Bioprocess Data Management". Hamburg & Jülich. |
2024-12-02 |
Bio Inx B.V.. (11/27/24). "Press Release: Bio Inx and Carl Roth Partner to Expand Access to 3D Bioprinting Solutions". Ghent. |
2024-11-27 |
Saniona AB. (11/26/24). "Press Release: Saniona Announces Licensing Agreement with Acadia Pharmaceuticals for SAN711 in Neurological Diseases". |
2024-11-26 |
Acadia Pharmaceuticals Inc.. (11/26/24). "Press Release: Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711". San Diego, CA. |
2024-11-26 |
Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA. |
2024-11-20 |
CRISPR Therapeutics AG. (11/14/24). "Press Release: CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference". Zug & Boston, MA. |
2024-11-14 |
BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz. |
2024-11-13 |
Mainz Biomed N.V.. (11/12/24). "Press Release: Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets". Berkeley, CA & Mainz. |
2024-11-12 |
CRISPR Therapeutics AG. (11/7/24). "Press Release: CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference". Zug & Boston, MA. |
2024-11-07 |
Valanx Biotech GmbH. (10/29/24). "Press Release: Valanx Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development". Klosterneuburg & Rockville, MD. |
2024-10-29 |
Aignostics GmbH. (10/29/24). "Press Release: Aignostics Secures $34M Series B to Enhance Precision Medicine with AI". Berlin & New York, NY. |
2024-10-29 |
Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA. |
2024-10-28 |
AbbVie Inc.. (10/24/24). "Press Release: AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions". North Chicago, IL & Budapest. |
2024-10-24 |
Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing
> Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA. |
2024-10-16 |
SphingoTec GmbH. (10/9/24). "Press Release: Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care". Hennigsdorf. |
2024-10-09 |
Boehringer Ingelheim. (10/9/24). "Press Release: Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment". Ingelheim & South San Francisco, CA. |
2024-10-09 |
Yumab GmbH. (10/8/24). "Press Release: Yumab and Molcure Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets". |
2024-10-08 |
CrestOptics S.p.A.. (10/7/24). "Press Release: CrestOptics and Leica Microsystems Announce Strategic Collaboration to Expand Capabilities of Spinning Disk Microscopy". Rome. |
2024-10-07 |
Ten23 Health AG. (10/7/24). "Press Release: BD and Ten23 Health Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-enabled Prefillable Syringes". Franklin Lakes, NJ & Basel. |
2024-10-07 |
Aitiologic GmbH. (10/1/24). "Press Release: Aitiologic Emerges from Stealth Mode with over €2.5M in Funding to Advance AI-powered Liquid Biopsy Platform for Early Disease Detection". Vienna. |
2024-10-01 |
1BillionLives GmbH (d/b/a Flinn). (9/30/24). "Press Release: Flinn.ai Secures 10 Million Euros in Less than 18 Months". |
2024-09-30 |
Regor Pharmaceuticals (USA). (9/30/24). "Press Release: Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of Next-generation CDK Inhibitors for the Treatment of Breast Cancer". Cambridge, MA. |
2024-09-30 |
Evotec SE. (9/26/24). "Press Release: Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-generation Cell Therapies". Hamburg. |
2024-09-26 |
Generative:Biomedicines. (9/24/24). "Press Release: Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with Generative AI". Somerville, MA. |
2024-09-24 |
Symrise AG. (9/20/24). "Press Release: Symrise and Shan Foods Inaugurate a State-of-the-Art International Standard Production Facility for Its Strategic Partnership in Pakistan". Dubai, Holzminden & Karachi. |
2024-09-20 |
Oribiotech Ltd.. (9/18/24). "Press Release: Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing". Philadeliphia, PA. |
2024-09-18 |
NanoVation Therapeutics Inc.. (9/18/24). "Press Release: NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases". Vancouver, BC. |
2024-09-18 |
Bioké (Cell Signaling Technology Europe B.V.). (9/16/24). "Press Release: Bioké and e-Blot Announce a Distribution Agreement in the European Region". Leiden. |
2024-09-16 |
Organon & Co.. (9/12/24). "Press Release: Organon Enters into Licensing Agreement with Bao Pharmaceutical and Its Wholly-owned Subsidiary Centergene Pharmaceuticals". Shanghai. |
2024-09-12 |
Qiagen N.V.. (9/12/24). "Press Release: Qiagen and Bio-Manguinhos/Fiocruz Collaborate to Enhance Malaria and Dengue Detection in Brazil’s National Screening Programs". Venlo & Rio de Janeiro. |
2024-09-12 |
Cellular Origins Ltd.. (9/11/24). "Press Release: Cellular Origins and 3P Innovation Collaborate to Accelerate Industrialisation of CGT Manufacturing". Cambridge. |
2024-09-11 |
Roivant Sciences GmbH. (9/10/24). "Press Release: Roivant Unveils New Pipeline Program Mosliciguat, a Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator". Basel, London & New York, NY. |
2024-09-10 |
Genedata AG. (9/5/24). "Press Release: Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics". Basel. |
2024-09-05 |
Qiagen N.V.. (9/4/24). "Press Release: Qiagen and Lilly Collaborate to Support Development of a QIAstat-Dx IVD Panel that Identifies Patients at Risk for Developing Alzheimer’s disease". Venlo. |
2024-09-04 |
Haya Therapeutics SA. (9/4/24). "Press Release: Haya Therapeutics Announces Collaboration with Lilly to Discover Novel Regulatory Genome Targets for Obesity and Related Metabolic Conditions Using Proprietary RNA Platform". Lausanne & San Diego, CA. |
2024-09-04 |
Tempus AI, Inc.. (9/4/24). "Press Release: Tempus Announces Real World Data Collaboration with BioNTech". Chicago. |
2024-09-04 |
ERS Genomics Ltd.. (9/4/24). "Press Release: ERS Genomics and Medicines Discovery Catapult Sign CRISPR/Cas9 License Agreement". Dublin & Cheshire. |
2024-09-04 |
Mainz Biomed N.V.. (9/4/24). "Press Release: Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert". Berkeley, CA & Mainz. |
2024-09-04 |
Molport Inc.. (9/3/24). "Press Release: Molport Welcomes Diana Zelencova-Gopejenko as CEO". Riga. |
2024-09-03 |
Nxera Pharma Co., Ltd.. (9/2/24). "Press Release: Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568". Tokyo & Cambridge. |
2024-09-02 |
Qiagen N.V.. (8/28/24). "Press Release: Qiagen Expands QIAstat-Dx into Precision Medicine through Partnership for Companion Diagnostics in Chronic Diseases". Venlo. |
2024-08-28 |
Lindy Biosciences Inc.. (8/28/24). "Press Release: Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation". Raleigh, NC. |
2024-08-28 |
Exscientia plc. (8/28/24). "Press Release: Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference". Oxford. |
2024-08-28 |
NextRNA Therapeutics, Inc.. (8/28/24). "Press Release: Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-coding RNAs (lncRNAs) in Oncology". Berlin & Boston, MA. |
2024-08-28 |
InflaRx N.V.. (8/27/24). "Press Release: InflaRx Announces Participation in September Investor Events". Jena. |
2024-08-27 |
Bruker Corporation. (8/23/24). "Press Release: Bruker Corporation to Present at Upcoming Investor Conferences". Billerica, MA. |
2024-08-23 |
Versant Ventures. (8/22/24). "Press Release: Versant Ventures and Novartis Launch Borealis Biosciences with $150 Million in Funding". Vancouver, BC. |
2024-08-22 |
Coulter Partners. (8/22/24). "Press Release: Coulter Partners Places Industry Veteran Dr. David Hung as Chair of T-Therapeutics". |
2024-08-22 |
Novartis AG. (8/22/24). "Press Release: Novartis Employs Creative Deal Structure to Establish Borealis Biosciences – Divests Legacy Chinook Site, Invests to Form New Company and Engages in R&D collaboration". |
2024-08-22 |
Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai. |
2024-08-20 |
BioNTech SE. (8/19/24). "Press Release: Lift of Partial Clinical Hold for BNT326/YL202". |
2024-08-19 |
Enamine Ltd.. (8/15/24). "Press Release: Iniuva and Enamine Announce Strategic Collaboration to Advance Drug Discovery for Rare Genetic Diseases". Kyiv. |
2024-08-15 |
Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried. |
2024-08-08 |
AGC Biologics. (8/7/24). "Press Release: NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines". |
2024-08-07 |
Bruker Corporation. (8/7/24). "Press Release: Bruker Announces Strategic Minority Investment in Novalix". |
2024-08-07 |
IDRx, Inc.. (8/7/24). "Press Release: IDRx Announces $120 Million Series B Financing to Advance Potential Best-in-class New Treatment for Gastrointestinal Stromal Tumor (GIST)". Plymouth, MA. |
2024-08-07 |
Leon-Nanodrugs GmbH. (8/6/24). "Press Release: Leon-Nanodrugs Secures Funds in a Series D Financing to Broaden Portfolio in First Single-use High Throughput Production Systems for Nanoencapsulation". Munich. |
2024-08-06 |
Carbios S.A.. (8/6/24). "Press Release: Carbios and FCC Environment Announce Joint Project to Establish UK-based PET Biorecycling Facility Using Carbios’ Licensed Technology". Clermont-Ferrand & Doncaster. |
2024-08-06 |
Standard BioTools Inc.. (8/6/24). "Press Release: Standard BioTools to Participate in Upcoming Investor Conferences". South San Francisco, CA. |
2024-08-06 |
Sangamo Therapeutics, Inc.. (8/6/24). "Press Release: Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases". Richmond, CA. |
2024-08-06 |
Seres Therapeutics, Inc.. (8/6/24). "Press Release: Seres Therapeutics Announces Signing of Vowst Asset Purchase Agreement with Nestlé Health Science". Cambridge, MA. |
2024-08-06 |
Biomatter Designs. (8/5/24). "Press Release: Biomatter Raises a €6.5 Million Seed Round to Unlock the Power of Generative AI for Enzyme Design". Vilnius. |
2024-08-05 |
Pantherna Therapeutics GmbH. (8/1/24). "Press Release: BioSpring and Pantherna Agree on Strategic Cooperation in the Field of Genome Editing". Frankfurt a. M. & Hennigsdorf. |
2024-08-01 |
Systasy Bioscience GmbH. (7/31/24). "Press Release: Systasy Bioscience Announces Collaboration Agreement with Ono Pharmaceutical". Munich. |
2024-07-31 |
Dren Bio, Inc.. (7/24/24). "Press Release: Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer". Foster City, CA. |
2024-07-24 |
Kadans Science Partner. (7/24/24). "Press Release: Kadans Science Partner Commences Work on New Purpose-built Wet Lab Facilities at Merlin Place, North Cambridge". Cambridge. |
2024-07-24 |
Triastek, Inc.. (7/23/24). "Press Release: Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics". Nanjing. |
2024-07-23 |
Pinetree Therapeutics, Inc.. (7/23/24). "Press Release: Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca". Cambridge, MA. |
2024-07-23 |
Full-Life Technologies. (7/17/24). "Press Release: Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors". Heidelberg & Seoul. |
2024-07-17 |